November 12, 2025 · Form 4 insider transaction
Telman Deborah H sold 35,965 shares of Gilead Sciences, Inc. at $122.30 per share, a transaction worth $4.40M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.; Sales prices for the transactions reported here range from $121.87 to $122.83. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.